| scholarly article | Q13442814 |
| P356 | DOI | 10.2967/JNUMED.109.068361 |
| P698 | PubMed publication ID | 20395318 |
| P50 | author | Timothy F. Cloughesy | Q47159504 |
| P2093 | author name string | Wei Chen | |
| Christiaan Schiepers | |||
| Johannes Czernin | |||
| Michael E Phelps | |||
| Magnus Dahlbom | |||
| Sung-Cheng Huang | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 720-727 | |
| P577 | publication date | 2010-04-15 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma | |
| P478 | volume | 51 |
| Q36404866 | 18F-fluorothymidine PET imaging in gliomas: an update. |
| Q36179310 | 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab |
| Q36217442 | 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response |
| Q35864929 | An observational study of the first experience with bevacizumab for the treatment of patients with recurrent high-grade glioma in two belgian university hospitals |
| Q24605136 | Brain tumors |
| Q48465675 | Compartment modeling of dynamic brain PET--the impact of scatter corrections on parameter errors |
| Q37323697 | Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma |
| Q37496766 | Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft. |
| Q39700078 | Dynamic PET simulator via tomographic emission projection for kinetic modeling and parametric image studies. |
| Q38206772 | FLT PET-CT in evaluation of treatment response. |
| Q35636166 | Heterogeneity in stabilization phenomena in FLT PET images of canines |
| Q38894617 | Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model |
| Q40974417 | Image accuracy and quality test in rate constant depending on reconstruction algorithms with and without incorporating PSF and TOF in PET imaging |
| Q35895174 | Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. |
| Q48946602 | Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer |
| Q37999206 | Molecular imaging for personalized cancer care |
| Q37832131 | PET-CT for radiotherapy treatment planning and response monitoring in solid tumors |
| Q30577115 | PET/MRI for neurologic applications |
| Q39428846 | Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model |
| Q30907831 | Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response |
| Q48158155 | Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences |
| Q30275817 | Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma |
| Q90387668 | Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study |
| Q51742545 | Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study. |
| Q42124600 | The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology |
| Q47725129 | The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review. |
| Q36382036 | Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer |
Search more.